Objectives: Posttraumatic stress disorder (PTSD) prospectively increases the risk of incident cardiovascular disease (CVD) independent of other risk factors in otherwise healthy individuals. Between 10-20% of patients develop PTSD related to the traumatic experience of MI. We investigated the hypothesis that PTSD symptoms caused by myocardial infarction (MI) predict adverse cardiovascular outcome.
INTRODUCTION
Between 10 and 20% of patients develop posttraumatic stress disorder (PTSD) in the aftermath of acute myocardial infarction (MI) [1] [2] [3] [4] . To meet the diagnostic criteria for PTSD according to the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) [5] , patients must have perceived their MI as an event involving threatened death to which they responded with intense fear, helplessness, or horror (criterion A). Three characteristic PTSD symptom clusters (criteria B, C and D) must be present, referring to a) re-experiencing of MI, e.g., in thoughts and dreams, b) avoidance of MI-related stimuli, e.g., intake of cardiac medication, and c) hyperarousal, e.g., irritability and perturbed sleep [1] .
These clusters of symptoms must continue for at least one month during which they inflicted clinically significant distress or impairment in daily functioning.
Large scale epidemiologic studies found PTSD caused by different types of trauma increases the risk of incident cardiovascular disease (CVD), even when controlling for sociodemographic factors, major CVD risk factors, and depression [6] [7] [8] . In contrast, little is known about the prognostic value of PTSD caused by MI in terms of cardiovascular outcome. One previous study investigated 65 post-MI patients of which 13 qualified for PTSD attributable to MI defined by above-threshold PTSD symptoms (i.e., PTSD caseness) on the Impact of Event Scale [9] . In that study, case definition of PTSD predicted hospital readmissions owing to CVD events, including recurrent MI and unstable angina, at one-year follow-up. Therefore, we performed a prospective study on cardiovascular outcome (i.e., hospital readmissions because of CVD-related events and procedures) in a sizeable sample of patients with a previous index MI who self-rated MI-specific PTSD symptoms at study entry.
We hypothesized that elevated levels of PTSD symptoms caused by MI would increase the risk of a non-fatal CVD-related hospital readmission independent of demographic and medical covariates that may also adversely impact the prognosis of CHD. total PDS score (Cronbach's α =.91) and the 3 PTSD symptom cluster scores (criteria B, C, and D) of re-experiencing (α=.88), avoidance/numbing (α=.80), and hyperarousal (α=.76). In the questionnaire we replaced the term "event" with the term "heart attack" [2] . Patients rated on a 4-point scale how often they had experienced each symptom during the past month (0=not at all, 3=often) yielding a PTSD symptom severity score between 0-51 (reexperiencing: 0-15, avoidance: 0-21, hyperarousal: 0-15). Missing items were replaced with the mean of completed items of the respective symptom cluster. Table 1 summarizes the 17 items of the PDS according to symptom clusters B-D of PTSD [11] . The PDS performs well as a screening tool to identify clinical cases of PTSD [13] . A total PDS score ≥18 recently yielded the best balance between sensitivity and specificity for screening for PTSD (i.e., PTSD caseness) across different samples of trauma survivors (area under the ROC curve 0.90-0.96) [14] .
The PDS does not assess the DSM-IV criterion A2 for PTSD, i.e. to what extent the patients responded to the A1 event (i.e., the MI) with "intense fear, helplessness, or horror". Therefore, at the time when they completed the PDS, we asked the patients to retrospectively rate on a numeric scale "fear of dying" and "feelings of helplessness" they had perceived during MI. Specific items were (0 = absolutely not true, 10 = absolutely true) [2] : "During my referral to the hospital, the emergency unit, or the intensive care unit, I was afraid I was dying." and "When the doctor told me I had a heart attack, I was frightened, felt helpless, and was afraid of losing control over the situation."
Assessment at Follow-up
The follow-up period referred to the time interval between sending out the PDS to assess PTSD symptoms in relation to the index MI and a semi-structured telephone interview by using a standard protocol. During the interview patients were asked whether they had been hospitalized because of a new CVD event or CVD-related intervention. We assessed the following specific diagnostic categories and interventions by using a checklist (yes/no answers): recurrent MI, elective and non-elective intracoronary stenting, coronary artery bypass surgery, pacemaker implantation, cardiac arrhythmia, cardiac arrest, cerebrovascular insult, transient ischemic attack, hypertensive crisis, and chronic heart failure. If patients'
self-report about the cardiovascular cause for hospitalization was non-specific, their primary care physicians were contacted by telephone to verify the type of CVD-related event or intervention (all contacted physicians could be reached). We did not consider "angina pectoris" as a diagnostic category because chest pain has many cardiac and non-cardiac causes, one being psychological distress that is particularly high in traumatized subjects.
However, recurrence of chest pain previously predicted posttraumatic stress in patients 12 months after hospital admission for an acute coronary syndrome [15] . We thus asked about chest pain which had occurred since index MI having prompted patients to see a doctor but remained unexplained. We further asked patients whether they had received mental health treatment in the form of antidepressant medication and/or psychotherapy since the index MI.
Statistical Analysis
Data were analyzed using SPSS 15.0 statistical software package (SPSS Inc. Chicago, IL) with a significance level of p<0.05 (two-tailed). For calculations of differences between groups, Student's t test, Pearson chi-square test, and Fisher's exact test were used where appropriate. We ran Cox proportional hazard models to estimate the predictive value of posttraumatic stress severity (assessed by the PDS at study entry) for the relative risk of a hospital readmission during follow-up because of a CVD event or CVD-related intervention (combined endpoint). For this analysis we used the total PDS score as a continuous variable (i.e., the PDS cut-off ≥18 was only used to compute the prevalence of PTSD caseness and to compare characteristics between patients with high versus low PDS scores). Total PDS scores showed a skewed distribution towards small values. Although not normally distributed predictor variables have generally no impact on regression-type models [16] , we reran all models with normally distributed square root transformed total PDS scores; this procedure did not change the significance of posttraumatic stress as a predictor of CVD-related outcome (data not shown). Because a one point higher level on PDS scores predicts a change in the relative risk 2 that, even when being statistically significant, is unlikely of clinical relevance, we expressed the change in the hazard ratio (HR) with 95% confidence interval (CI) for a 10 point higher level on the total PDS score and for a 3 point higher level on the individual PTSD symptom scores. For this purpose total PDS scores and individual PTSD symptom scores were divided by 10 and 3, respectively, prior to entering them into the models.
Control variables that might potentially affect CHD outcome were defined a priori, whereby sex and age (demographic factors) were treated as control variables in all models.
To prevent over-fitted models given the number of endpoint events [16] , we first identified potentially relevant predictors of outcome. Together with sex and age, these were grouped into five separate blocks of covariates: 1) CHD severity: type of the index MI (first-time vs.
recurrent MI), number (1, 2, or 3) of diseased coronary vessels); 2) major CVD risk factors:
hypertension, diabetes, current smoking (all coded as yes/no); 3) cardiac medication prescribed at hospital discharge: aspirin, statins, beta blockers, ACE inhibitors (all coded as yes/no); 4) unexplained chest pain since index MI (coded as yes/no); and 5) mental health treatment since index MI: antidepressant medication, psychotherapy (both coded as yes/no).
Control variables emerging as outcome predictors (p<0.10) from these five blocks were entered into the final model together with sex, age, and posttraumatic stress (one block).
Adverse Cardiovascular Events During Follow-up
The mean duration of follow-up was 2.8 years (range 1.3-3.8) during which a CVDrelated hospital readmission occurred in 43 (14.5%) of the 297 post-MI patients who were available for follow-up. The 43 CVD-related events or interventions were 10 (3.4%) recurrent MIs, 13 (4.4%) non-elective stents, 11 (3.7%) elective stents, 4 (1.3%) coronary artery bypass surgeries, 1 (0.3%) pacemaker implantation, 1 (0.3%) cardiac arrhythmia, and 3 (1.0%) cerebrovascular events. There were no hospital readmissions because of cardiac arrest, hypertensive crisis, or chronic heart failure. Table 3 shows that for a 10 point higher level in the PDS score, there was a 45% to 
PTSD Symptoms and CVD-related Hospital Readmissions

Sensitivity Analyses
To test for the robustness of the above findings we performed five sensitivity analyses. We restrict the presentation of the results to the fully adjusted models, which controlled for sex, age, and hypertension status. All HRs refer to the increase in the relative risk of a CVD-related hospital readmission for a 10-point higher level in the total PDS score for the respective subsample. 
DISCUSSION
We found that elevated levels of PTSD symptoms caused by MI predicted the risk of future hospital readmissions due to a combined endpoint of non-fatal CVD events and CVDrelated interventions over a mean follow-up period of almost three years. This relationship was independent of several other potential predictors of adverse outcome. Results from five sensitivity analyses suggested the predictive value of posttraumatic stress for future non-fatal CVD-related hospital readmissions is robust. We further found that PTSD symptoms predicted poor cardiovascular outcome even when elective intracoronary stenting was not considered as an outcome. This may suggest that including elective stenting in our combined outcome did not dilute the "true" time interval after which hospital readmission became inevitable due to the progression of CHD.
Our findings suggest that the risk of adverse CVD-related outcome of post-MI patients lies along a continuum of PTSD symptom severity. Specifically, in the final multivariate-adjusted primary analysis, a 10 point higher level in the PDS score showed an increase of 42% in the relative risk for a CVD-related event. Moreover, 15.2% of MI survivors met a PDS cut-off score ≥18 which previously performed well as a screening tool for PTSD caseness in individuals with non-MI related traumas [14] . This prevalence of PTSD caseness largely concurs with that found in other samples of post-MI patients investigated in the first year after MI [1] , but it is several times higher than the 12-month prevalence of PTSD in a representative Swiss population sample [17] .
Because PTSD caused by MI is frequent and clinically important, clinicians may want to routinely assess PTSD symptomatology in their post-MI patients, even though it is currently unknown which treatment should be delivered and whether it may alleviate cardiovascular morbidity. We found that patients meeting PTSD caseness criteria were younger and seemed to have less severe CHD than non-PTSD cases. Hence it might be that the relatively younger post-MI patients with PTSD, but not necessarily those with more severe CHD, particularly benefit from PTSD treatment. One small study showed a decrease in MI-caused PTSD symptoms and CVD risk factor status after trauma-focused cognitive behavior therapy (CBT) plus education compared to education alone [18] . This finding is in line with the established knowledge that the most effective psychotherapies for PTSD are those focusing on the psychological trauma [19] . Importantly, trauma-focused CBT seems safe in patients with PTSD resulting from cardiovascular illness (incl. MI) since hemodynamic activity does not evidently increase during imaginal exposure therapy [20] . In addition, selective serotonin reuptake inhibitors (SSRIs) in sufficiently high doses are firstline drugs to treat PTSD [21] and SSRIs (but not tricyclic antidepressants, TCAs) are also safely administered to patients with CHD [22] . Interestingly enough, adjustments for psychotherapy and antidepressant medication did not reduce the risk of adverse outcome in relation to PTSD symptoms in our patients. It might be that traumatic experience of MI was not specifically addressed in those psychotherapies and that the dosage of antidepressants was too low to alleviate posttraumatic stress. However, it should also be noted that we did not have information about the type of prescribed antidepressants. Therefore, we cannot exclude the possibility that favourable effects of SSRIs on cardiovascular outcomes were outweighed by unfavourable effects of TCAs such that the overall effect of antidepressants was null.
Atherosclerotic mechanisms underlie the vast majority of CVD events and CVDrelated procedures that were considered as outcomes in our study. Although not investigated here, several pathophysiologic mechanisms might explain the atherosclerotic CVD risk associated with PTSD symptoms. These may particularly include low-grade systemic inflammation [1] . Neuroendocrine and autonomic alterations in PTSD are thought to mediate a dysfunctional peripheral stress response involving a range of immunological changes with the associated wear and tear to the body giving rise to the clinical manifestation of CVD and atherothrombotic events [23, 24] . There is particular evidence for altered hypothalamicpituitary adrenal axis function involving peripheral hypocortisolemia and a hyperadrenergic state in PTSD [25, 26] . Plasma levels of cortisol were lower and those of the proinflammatory cytokine interleukin-6 were higher in patients with PTSD caused by MI than in post-MI patients with no PTSD [27, 28] . Another study found a positive correlation between plasma norepinephrine and interleukin-6 levels in PTSD related to combat exposure [29] . Patients with PTSD may also have decreased vagal activity [30] . Vagal withdrawal might give rise to enhanced production of proinflammatory cytokines by tissue macrophages [31] , thereby potentially kindling inflammation in coronary arteries [32] .
We mention several limitations of our study. The link between PTSD and poor prognosis of CHD might also be mediated by low adherence to cardiac therapy [33] and adverse life style such as smoking, excessive alcohol consumption, low physical activity, and dietary habits promoting dyslipidemia and overweight [1] . We controlled for current smoking and statin use as a proxy measure of hyperlipidemia, but we had no information available about adherence, physical activity, diet, and body mass index to control for obesity. However, obesity has also been shown to be associated with reduced mortality after ST-elevation MI [34] in which case the controlling for obesity should have theoretically strengthened the predictive value of posttraumatic stress for CVD-related hospital readmissions. It would have further strengthened our study if we had also taken into account as covariates important prognostic factors like cholesterol levels, prevalence of pre-infarction angina, Killip class, left ventricular function, and peak levels for cardiac enzymes. The window for sending the questionnaire was one year such that we cannot fully rule out that some cases of PSTD that resolved before the assessment was made. It is also possible that more severe and prolonged chest pain before MI and between MI and PTSD assessment had contributed to the level of posttraumatic stress [15] . However, we adjusted for CHD severity, unexplained chest pain since index MI, and the time interval between index MI and PTSD assessment; moreover, the prevalence of PTSD did previously not decrease with longer time elapsed within the first year since MI [1] . We did not assess other psychosocial risk indicators for post-MI prognosis such as low social support [35] and depression [36] both of which are also associated with PTSD in cardiac patients [15, 37] . However, PTSD symptoms previously predicted incident CVD independent of depression [6] [7] [8] and some authors argue that separating out depression as a distinct disorder when it occurs with PTSD more than one year after trauma is an arbitrary distinction [38] . Moreover, we found that PTSD specific symptoms of reexperiencing MIrelated cues were individually predictive of poor CVD-related outcome. Antidepressant medication (i.e., a surrogate of clinical depression) was not a significant predictor of outcome and dropping patients with antidepressant medications also maintained the predictive value of posttraumatic stress. Although avoidance and hyperarousal symptoms, which are less specific to PTSD, were also individually predictive of adverse outcome, our findings suggest that components unique to PTSD added to poor post-MI prognosis above and beyond aspects related to depression. Figure 1 
